Previous studies have shown that FGF2 expression was transcriptionally suppressed by Dach1 in glioma cells [27] and on the contrary, FGF2 was shown to activate DACH1 during skeletal development in mouse [28]. The gene discussed is FGF2; the disease is central nervous system cancer.